AI Medical Compendium Journal:
BMC cancer

Showing 31 to 40 of 162 articles

Development of PDAC diagnosis and prognosis evaluation models based on machine learning.

BMC cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and highly aggressive, often leading to poor patient prognosis. Existing serum biomarkers like CA19-9 are limited in early diagnosis, failing to meet clinical needs. Mac...

A semi-supervised convolutional neural network for diagnosis of pancreatic ductal adenocarcinoma based on EUS-FNA cytological images.

BMC cancer
BACKGROUND: The cytological diagnostic process of EUS-FNA smears is time-consuming and manpower-intensive, and the conclusion could be subjective and controversial. Moreover, the relative lack of cytopathologists has limited the widespread implementa...

Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma.

BMC cancer
OBJECTIVES: The potential of medical imaging to non-invasively assess intratumoral heterogeneity (ITH) is increasingly being recognized. This study aimed to investigate the value of the ITH-based deep learning model for preoperative prediction of his...

Deep learning radiomics for the prediction of epidermal growth factor receptor mutation status based on MRI in brain metastasis from lung adenocarcinoma patients.

BMC cancer
BACKGROUND: Early and accurate identification of epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients with brain metastases is critical for guiding targeted therapy. This study aimed to develop a deep...

Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study.

BMC cancer
BACKGROUND AND OBJECTIVE: Spread through air spaces (STAS) is an important factor in determining the aggressiveness and recurrence risk of lung cancer, especially in early-stage adenocarcinoma. Preoperative identification of STAS is crucial for optim...

Auxiliary meta-learning strategy for cancer recognition: leveraging external data and optimized feature mapping.

BMC cancer
As reported by the International Agency for Research on Cancer (IARC), the global incidence of cancer reached nearly 20 million new cases in recent years, with cancer-related fatalities amounting to around 9.7 million. This underscores the profound i...

The feasibility and cost-effectiveness of implementing mobile low-dose computed tomography with an AI-based diagnostic system in underserved populations.

BMC cancer
BACKGROUND: Low-dose computed tomography (LDCT) significantly increases early detection rates of lung cancer and reduces lung cancer-related mortality by 20%. However, many significant screening barriers remain. This study conduct an initial feasibil...

Preoperative clinical radiomics model based on deep learning in prognostic assessment of patients with gallbladder carcinoma.

BMC cancer
OBJECTIVE: We aimed to develop a preoperative clinical radiomics survival prediction model based on the radiomics features via deep learning to provide a reference basis for preoperative assessment and treatment decisions for patients with gallbladde...

Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer.

BMC cancer
BACKGROUND: Bladder cancer (BLCA) exists a profound molecular diversity, with basal and luminal subtypes having different prognostic and therapeutic outcomes. Traditional methods for molecular subtyping are often time-consuming and resource-intensive...